Alzheimer's disease July 14, 2021 6:21 pm Insurers Debate Coverage for New Alzheimer's Drug Insurance companies are weighing whether to cover Biogen’s controversial new drug for Alzheimer’s disease, which has an annual cost of $56,000. US & World Videos 1:17 Patriots player visits Franciscan Children's Hospital 5:54 Pro-Palestinian protest taking over college campuses 2:47 AI pharmacist? Brigham testing new tech to assist docs, pharmacists 3:56 Five things you need to know about buying a home 1:38 Chelsea announces plan for facelift
